These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28110135)

  • 1. Identification of hereditary hemochromatosis pedigrees and a novel SLC40A1 mutation in Chinese population.
    An P; Jiang L; Guan Y; Wang H; Wang J; Tian Y; Yang W; Shi Y; Xue J; Min J; Wang F
    Blood Cells Mol Dis; 2017 Mar; 63():34-36. PubMed ID: 28110135
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of HFE mutations and non-HFE gene mutations (TFR2 and SLC40A1) in patients with phenotypic hemochromatosis from the Basque Country.
    Castiella A; Zapata E; De Juan MD; Zubiaurre L; Iribarren A; Otazua P; Fernandez J; Aragón L; Zuriarrain O; Gorostidi A
    Int J Lab Hematol; 2016 Feb; 38(1):e5-7. PubMed ID: 26547814
    [No Abstract]   [Full Text] [Related]  

  • 3. Two middle-age-onset hemochromatosis patients with heterozygous mutations in the hemojuvelin gene in a Chinese family.
    Li S; Xue J; Chen B; Wang Q; Shi M; Xie X; Zhang L
    Int J Hematol; 2014 Apr; 99(4):487-92. PubMed ID: 24584909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis.
    Wang Y; Du Y; Liu G; Guo S; Hou B; Jiang X; Han B; Chang Y; Nie G
    Int J Hematol; 2017 Apr; 105(4):521-525. PubMed ID: 27896572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature.
    Zhang W; Lv T; Huang J; Ou X
    Medicine (Baltimore); 2017 Sep; 96(38):e8064. PubMed ID: 28930842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4.
    Chen SR; Yang LQ; Chong YT; Jie YS; Wu YK; Yang J; Lin GL; Li XH
    Intern Med J; 2015 Jun; 45(6):672-6. PubMed ID: 26059880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of a diagnostic algorithm hyperferritinemia: A case report of a Spanish family with hereditary hemochromatosis and mutation in SLC40A1 gene].
    Vargas JA; Muñoz A; Samper B; Bornstein B
    Med Clin (Barc); 2015 Jul; 145(1):42-3. PubMed ID: 25441019
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron overload in the Asian community.
    Lok CY; Merryweather-Clarke AT; Viprakasit V; Chinthammitr Y; Srichairatanakool S; Limwongse C; Oleesky D; Robins AJ; Hudson J; Wai P; Premawardhena A; de Silva HJ; Dassanayake A; McKeown C; Jackson M; Gama R; Khan N; Newman W; Banait G; Chilton A; Wilson-Morkeh I; Weatherall DJ; Robson KJ
    Blood; 2009 Jul; 114(1):20-5. PubMed ID: 19342478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
    Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism.
    Honma Y; Karasuyama T; Kumamoto K; Shimajiri S; Toki Y; Tatsumi Y; Sumida K; Koikawa K; Morino K; Oe S; Miyagawa K; Yamasaki M; Shibata M; Abe S; Ikuta K; Hayashi H; Harada M
    Med Mol Morphol; 2021 Mar; 54(1):60-67. PubMed ID: 32607777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype.
    Lee PL; Gelbart T; West C; Barton JC
    Acta Haematol; 2007; 118(4):237-41. PubMed ID: 18160816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
    Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
    Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain.
    Bach V; Remacha A; Altés A; Barceló MJ; Molina MA; Baiget M
    Blood Cells Mol Dis; 2006; 36(1):41-5. PubMed ID: 16257244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
    Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
    Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous presentation of hereditary hyperferritinaemia cataract syndrome and hereditary haemochromatosis.
    Maccora KA; Souzeau E; Ruddle JB; Craig JE
    Clin Exp Ophthalmol; 2018 Nov; 46(8):962-964. PubMed ID: 29737619
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China.
    Wu L; Zhang W; Li Y; Zhou D; Zhang B; Xu A; Wu Z; Wu L; Li S; Wang X; Zhao X; Wang Q; Li M; Wang Y; You H; Huang J; Ou X; Jia J
    Orphanet J Rare Dis; 2021 Sep; 16(1):398. PubMed ID: 34583728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
    Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic background of primary iron overload syndromes in Japan.
    Hayashi H; Wakusawa S; Motonishi S; Miyamoto K; Okada H; Inagaki Y; Ikeda T
    Intern Med; 2006; 45(20):1107-11. PubMed ID: 17106152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of hereditary hemochromatosis.
    Salgia RJ; Brown K
    Clin Liver Dis; 2015 Feb; 19(1):187-98. PubMed ID: 25454304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.